论文部分内容阅读
1.临床资料本组33例中,男22例,女11例,年龄12～61岁,平均39岁,除合理化疗方案外,执行6个月化疗27例,9个月6例.统一报告卡:我们采用“结核病人登记报告卡”以登记病例来源及发现方式、诊断、初(复)治,始治方案、随访治疗和提高对结核病人治疗管理质量,也可作为疫情报告制度.统一化疗方案:化疗方案均以2SHRZ/4HR和2SHRZ/7HRE为主,对链霉素(S)禁忌的患者选用2EHRZ/4H_3R_3或2EHRZ/7H_2R_2
1. Clinical data The group of 33 patients, 22 males and 11 females, aged 12 to 61 years, mean 39 years, with the exception of rational chemotherapy, the implementation of 6 months of chemotherapy in 27 cases, 9 months in 6 cases. Card: We also use the Tuberculosis Register Report Card to register the source of the disease and how it is found, diagnosis, primary (re-treatment), initial treatment, follow-up and treatment management and to improve the quality of treatment and management of tuberculosis patients. Chemotherapy regimens: Chemotherapy regimens are mainly 2SHRZ / 4HR and 2SHRZ / 7HRE, 2EHRZ / 4H_3R_3 or 2EHRZ / 7H_2R_2 are used for patients with contraindications to streptomycin (S)